Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(73)
•••
Sailboatdream
X
View Profile
View Bullboard History
Comment by
Sailboatdream
on May 05, 2022 6:35am
RE:number 1
Good morning Charly. Number 1 with what? The functional cure and solution? Ok - we agree. But they certainly are not number 1 in terms of communication, investor
...more
(239)
•••
Charly50
X
View Profile
View Bullboard History
Post by
Charly50
on May 05, 2022 4:12am
number 1
Whoever says the word "idiot" a hundred times is a clear favorite for re-election as CEO in the idiot club. Don't worry, they're number 1
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 04, 2022 1:54pm
RE:YTD lows…
The deal is just around the corner....that's if the corner is 3022.
(73)
•••
Sailboatdream
X
View Profile
View Bullboard History
Post by
Sailboatdream
on May 04, 2022 1:01pm
YTD lows…
Competition is in shambles... not a peep from Sernova. Endless hints at deal(s) continues to not materialize. "Imminent" TSX listing continues to be elusive. Unable to
...more
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on May 03, 2022 6:13pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Vertex Trial on Hold
Oh please, you are yet to come up with an original post, original idea, any insight or anything of any substance. I think you've literally only ever commented on other peoples posts and its always
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on May 03, 2022 4:42pm
RE:RE:RE:RE:Neutropenia
Red, I agree there is more going on here with Vertex . Eventually the truth will come out . Sva has to stay focussed and complete the trial . Get pat 7 to show insulin independence WITHOUT
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on May 03, 2022 4:16pm
RE:RE:RE:Neutropenia
Metals I agree its critical. My point was for Vertex injecting into potal vein it puts them at a higher risk needing more immonsupression. I also question why the FDA would put a stop to a
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 03, 2022 2:18pm
RE:RE:RE:RE:RE:RE:RE:RE:Vertex Trial on Hold
you are an idiot MoneyMouth. Stick to your street corner and knee pads.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 03, 2022 2:16pm
RE:RE:Neutropenia
@Red. Now don't be silly. Of course there are other known pathways to neutropenia but only an idiot would design a trial that did not screen out those people. My point that you have clearly missed
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on May 03, 2022 10:41am
Limited downside...
Unless the general market craps the bed. Good buys at these prices to hold for a flip. Not much on the offer however.
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on May 03, 2022 2:19am
RE:RE:RE:RE:RE:RE:RE:Vertex Trial on Hold
And if I had a penny for every one that didn't work preclinically, but then worked clinically, I'd also have zip, nada nothing... and live in a fantasy land where preclinical results didnt
...more
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on May 03, 2022 2:14am
RE:RE:RE:RE:RE:RE:RE:Vertex Trial on Hold
That has nothing to do with diabetes. Its about preventing certain molecules from diffusing and allowing others. This shows huge promise for the technology. However it was evident by the side by side
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on May 02, 2022 11:56pm
RE:Neutropenia
Metals Neutropenia can be a side effect of immunosuppressive drugs but there are also many other ways it can manifest. Also you have to take into account that the liver is front line immune
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on May 02, 2022 10:08pm
RE:RE:RE:RE:RE:RE:Vertex Trial on Hold
MoneyMouth, if I had a penny for every drug or device that worked in preclinical studies, I would have retired decades ago. Preclinical means zip..nada..nothing.
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >